Evidence map›Paper›PMID 27703968›Full record

ArticleBioMed research international2016

G-1639A but Not C1173T

Yevhen I Dubovyk, Viktoriia Yu Harbuzova, Alexander V Ataman

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Genes · 2020
    Observational
  6. Article
  7. The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018
    Article
  8. Positive Association betweenDisease markers · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yevhen I DubovykDepartment of Physiology, Pathophysiology and Medical Biology, Sumy State University, Sumy 40007, Ukraine.ORCID 0000-0002-6720-8397
Viktoriia Yu HarbuzovaScientific Laboratory of Molecular Genetic Research, Sumy State University, Sumy 40007, Ukraine.
Alexander V AtamanDepartment of Physiology, Pathophysiology and Medical Biology, Sumy State University, Sumy 40007, Ukraine.
Sumy State University · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin K epoxide reductase complex subunit 1 (VKORC1) is integral 163-amino acid long transmembrane protein which mediates recycling of vitamin K 2,3-epoxide to vitamin K hydroquinone and it is necessary for activation of vitamin K-dependent proteins (VKDPs). Herein, the association between G-1639A (rs9923231) and C1173T (rs9934438) single-nucleotide polymorphisms (SNPs) of the

Indexed as

AllelesHaplotypesPolymorphism, Single NucleotideAdultAgedAged, 80 and overBrain IschemiaFemaleGenotyping TechniquesHumansMaleMiddle AgedRisk FactorsStrokeUkraineVitamin K Epoxide ReductasesVitamin K Epoxide ReductasesVKORC1 protein, human

Identifiers

PMID27703968
PMCPMC5040782
OpenAlexW2520822234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.